M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
JiaWei Z, ChunXia D, CunDong L, Yang L, JianKun Y, HaiFeng D, Cheng Y, ZhiPeng H, HongYi W, DeYing L, ZhiJian L, Xiao X, QiZhao Z, KangYi X, WenBing G, Ming X, JunHao Z, JiMing B, ShanChao Z, MingKun C.
JiaWei Z, et al. Among authors: yang l.
Ann Med. 2021 Dec;53(1):730-740. doi: 10.1080/07853890.2021.1924396.
Ann Med. 2021.
PMID: 34032524
Free PMC article.